General Motors Firm (NYSE:GM) [Trend Analysis] increased reacts as active mover, shares a gain 2.42% to traded at $33.81 and the percentage gap among open changing to regular change was -0.58%. General Motors (GM) reported that it is reinventing itself. And it’s found some partners for its recent effort. As part of the firm’s transformation from a traditional automotive firm to a business that will redefine personal mobility, GM has partnered with Herman Miller and Green Standards to repurpose tens of thousands of pieces of office furniture and equipment.
The pilot program is predictable to benefit about 100 Michigan-based community organizations, with a focus on Detroit, according to a report on the GM website. The Herman Miller rePurpose Program, managed by environmental firm Green Standards, is an industry-leading solution for managing surplus corporate assets through a combination of resale, recycling and donation.
Through rePurpose, GM will divert from the landfill around all existing furniture, equipment and supplies resulting from current renovations. Those are happening at GM’s Technical Center in Warren, the Proving Ground in Milford and global headquarters in Detroit. GM will reallocate some assets to other firm locations. The firm’s current ratio calculated as 0.90 for the most recent quarter. The firm past twelve months price to sales ratio was 0.32 and price to cash ratio remained 2.17. As far as the returns are concern, the return on equity was recorded as 32.80% and return on investment was 7.00% while its return on asset stayed at 6.70%. The firm has total debt to equity ratio measured as 1.77.
Amedica Corporation (NASDAQ:AMDA) [Trend Analysis] attempts to attain leading position in street, Shares price changes as it -30.00% to close at $0.74 with the total traded volume of 6.32 Million shares. Amedica Corporation (NASDAQ: AMDA) reported appointment of Dana Lyons as Vice President of Sales and Marketing. Mr. Lyons will lead the effort to raise the adoption of silicon nitride implants in the spinal fusion market and deliver income growth. He brings over 27 years of sales and sales management experience in the medical device industry. Mr. Lyons stated: “I am excited to join Amedica at a critical turn-about stage, when the spine market is looking for a new material platform. We can drive the adoption of silicon nitride in the spinal fusion market, where it is the perfect solution for relevant clinical concerns. The exclusive material attributes of silicon nitride create an iaccord choice for spinal fusion surgery.”
The FDA also notified the firm that the new pedicle screw system, Taurus, has been cleared for commercialization. The firm is on target for surgical implantation and a full market launch of the Taurus system by the end of the year. Mr. Lyons will execute a strategy for expanded introduction of new spine products, such as the lateral lumbar fusion devices and the Taurus pedicle screw system. “Authorization of our metals product portfolio is immediately relevant, and our new sales team will work toward proper positioning of this system, to leverage surgeon interest and drive income growth,” stated Dr. Bal. The firm has institutional ownership of 7.90%, while insider ownership included 6.96%. Its price to sales ratio ended at 1.15. AMDA attains analyst recommendation of 1.50 with week performance of -16.48%.